fbpx
Southeastern

Life Digest

Sort by:
Filter by Resource Type:
Filter Options »
Filter by Topic:
Filter by Author:
Filter by Scripture:
Filter by Event:
Filter by Media Format:

LIFE DIGEST: ‘Scary’ account of first human cloning effort published; E.U. to continue stem cell funding; womb transplants for women may be possible in 5 years

"[University of Kentucky scientist Zavos] told me then that he didn't have time to think about the ethical issues of human cloning; he was too busy pushing the scientific envelope."
Ben Mitchell
Trinity Evangelical Divinity School
WASHINGTON (BP)--The first published account of an attempt to clone a human baby demonstrates how far short of his goal a would-be cloning pioneer fell but how dangerous he remains, biomedical specialists said.
      Panos Zavos of the University of Kentucky reported July 20 in a little-known scientific journal he was able to produce an embryo who reached the four-cell stage before being implanted in a 35-year-old woman’s womb. Blood tests two weeks later showed the woman was not pregnant, according to the Guardian Unlimited, a British online newspaper.
      Zavos told the Guardian he had since transferred cloned embryos to five more women, but none had become pregnant.

LIFE DIGEST: New test in Britain likely to mark more
embryos for death; Wilmut endorses reproductive cloning

WASHINGTON (BP)--A breakthrough in genetic testing likely will mean intentional destruction for more human embryos.

LIFE DIGEST: 3 abortion clinics in U.S. shut down; …

Women’s Services was Omaha’s only abortion clinic. Pro-life advocates estimated as many as 60,000 abortions were performed at the clinic during its 33 years of operation.
WASHINGTON (BP)--Three abortion clinics that were responsible for the deaths of tens of thousands of unborn children have closed in recent weeks in the United States. The clinics were:
      -- Women’s Services P.C. in Omaha, Neb.;
      -- Central Women’s Services in Wichita, Kan.;
      -- Summit Medical Center in Birmingham, Ala.

LIFE DIGEST: Supreme Court to hear second partial-birth abortion case; challenge of S.D. law qualifies for ballot

WASHINGTON (BP)--The United States Supreme Court agreed June 19 to review a second case involving the federal Partial-birth Abortion Ban Act.

LIFE DIGEST: La. governor says she will not veto abortion ban; supporters of S.D. law may challenge petitions for vote; …

WASHINGTON (BP)--Louisiana may soon be on record as outlawing most abortions if, and when, the United States Supreme Court reverses its 1973 decision invalidating state bans on the procedure.

LIFE DIGEST: Minor defects resulting in abortions in England; poor babies target of letter to Clinton promoting RU 486; …

WASHINGTON (BP)--Unborn babies with correctable defects to their hands and feet are being aborted late in pregnancy in Great Britain.

LIFE DIGEST: Alabama closes Birmingham abortion clinic after multiple violations; …

WASHINGTON (BP)--The state of Alabama has shut down a Birmingham abortion clinic for numerous infractions, including giving RU 486 to a woman late in her pregnancy.

LIFE DIGEST: Panelists disagree on RU 486’s dangers; House rejects military abortions; …

WASHINGTON (BP)--Health experts disagreed about the role RU 486 has played in the deaths of several American women and what should be done about the abortion drug during a one-day panel discussion May 11.

LIFE DIGEST: Support for Roe dips to new low in survey; Andrea Clark dies; Euthanasia up in Netherlands; …

WASHINGTON (BP)--The American public’s support for Roe v. Wade has reached its lowest point since the Supreme Court issued that 1973 decision legalizing abortion, according to a new survey.

LIFE DIGEST: Talent reveals stance on destructive embryo initiative; poll shows Americans unaware of Roe’s effect

WASHINGTON (BP)--Sen. Jim Talent, who stunned pro-life advocates in February by withdrawing his longstanding support for a federal ban on human cloning, has announced his opposition to a ballot initiative in his home state that would permit destructive embryonic stem cell research.